Trials / Unknown
UnknownNCT06040424
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination in pMDI Form and Ipratropium and Salbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare the acute bronchodilator effect of pMDI formed Ipratropium / Levosalbutamol 20 mcg / 50 mcg fixed dose combination or pMDI formed Salbutamol 100 mcg Inhaler and Ipratropium 20 mcg Inhalation Aerosol in combination in stable moderate-severe-very severe COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Ipratropium / Levosalbutamol Fixed Dose Combination | New combination test treatment |
| DRUG | Ipratropium + Levosalbutamol Free Dose Combination | Free combination control treatment |
Timeline
- Start date
- 2023-09-28
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2023-09-15
- Last updated
- 2023-10-03
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06040424. Inclusion in this directory is not an endorsement.